1. Resistance to dopamine agonists in the treatment of prolactinomas: diagnostic criteria, mechanisms and ways to overcome it
   Irena A. Ilovayskaya et al, 2024, Almanac of Clinical Medicine CrossRef
2. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
   Eduardo J. Medina et al, 2023, Frontiers in Endocrinology CrossRef
3. Giant prolactinomas, a detailed analysis of 196 adult cases
   Billion Lisa et al, 2023, Pituitary CrossRef
4. Individual approach in the treatment of prolactinoma in a patient with multiple endocrine neoplasia type 1 syndrome
   E. N. Kravchuk et al, 2022, Russian Journal for Personalized Medicine CrossRef
5. Epilepsy associated with pituitary neuroendocrine tumors: Current status of problem and interdisciplinary approach
   A. V. Vasilenko et al, 2022, Medical alphabet CrossRef
6. Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy
   Maria-Magdalena Georgescu et al, 2022, Cell Communication and Signaling CrossRef
7. Modern concepts of genetic and immunohistochemical features of prolactin-secreting pituitary adenomas
   A. S. Shutova et al, 2023, Problems of Endocrinology CrossRef